Preoperative XXXX and poor prognostic factors in @entity1204 .

@entity1 @entity1204 @entity1148 @entity797 @entity3
This study aimed to evaluate the prevalence of preoperative @entity1148 and its prognostic significance in Thai @entity1 with @entity1204 . We retrospectively reviewed the medical records of 238 cases who had undergone surgical staging procedures between January 2005 and December 2008. Associations between clinicopathological variables and preoperative platelet counts were analyzed using Pearson's chi square or two- tailed Fisher's exact tests. Survival analysis was performed with Kaplan-Meier estimates. Univariate and @entity797 - regression models were used to evaluate the prognostic impact of various factors including platelet count in terms of disease-free survival and overall survival. The mean preoperative platelet count was 315,437/ L (SD 100,167/  L). @entity1 who had advanced stage, adnexal involvement, lymph node @entity3 , and positive peritoneal cytology had significantly higher mean preoperative platelet counts when compared with those who had not. We found @entity1148 (platelet count greater than 400,000/ L) in 18.1% of our @entity1 with @entity1204 . These had significant higher rates of advanced stage, cervical involvement, adnexal involvement, positive peritoneal cytology, and lymph node involvement than @entity1 with a normal pretreatment platelet count. The 5-year disease-free survival and overall survival were significantly lower in @entity1 who had @entity1148 compared with those who had not (67.4% vs. 85.1%, p=0.001 and 86.0% vs. 94.9%, p=0.034, respectively). @entity1148 was shown to be a prognostic factor in the univariate but not the multivariate analysis. In conclusion, presence of @entity1148 is not uncommon in @entity1204 and may reflect unfavorable prognostic factors but its prognostic impact on survival needs to be clarified in further studies.
